However, the expansion of certain NK subsets (c5-IL7, c6-IL15, and c11-TNFSF8) was not observed in this external dataset, indicating a potential association specifically with NK-based therapy in pancreatic cancer and warranting further functional investigation. This evidence concerns the gene C6 and familial pancreatic carcinoma.